Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Merrick

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Urology|July 9, 2002
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Cancer Journal (Sudbury, Mass.)|August 20, 2002
Biochemical outcome for hormone-naïve patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapySubir Nag, Rodney J Ellis, Gregory S Merrick, et al.
Urology|May 1, 2016
Pathology and Quality of Life Outcomes Following Office-based Transperineal Prostate BiopsyGregory S Merrick, Sarah Irvin, Ryan Fiano, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate glandGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Long-term urinary quality of life after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2009
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
American Journal of Clinical Oncology|October 7, 2003
Extracapsular radiation dose distribution after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Prostate-specific antigen spikes after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|October 31, 2009
Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Urology|July 9, 2002
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
Cancer Journal (Sudbury, Mass.)|August 20, 2002
Biochemical outcome for hormone-naïve patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiationGregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapySubir Nag, Rodney J Ellis, Gregory S Merrick, et al.
Urology|May 1, 2016
Pathology and Quality of Life Outcomes Following Office-based Transperineal Prostate BiopsyGregory S Merrick, Sarah Irvin, Ryan Fiano, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate glandGregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Long-term urinary quality of life after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2009
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
American Journal of Clinical Oncology|October 7, 2003
Extracapsular radiation dose distribution after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2002
Prostate-specific antigen spikes after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|October 31, 2009
Factors impacting all-cause mortality in prostate cancer brachytherapy patients with or without androgen deprivation therapyAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Pageof 19